{"id":"CHEMBL1002","canonicalSmiles":"CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1","inchiKey":"NDAUXUAQIAJITI-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOSALBUTAMOL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASF-1096","Albuterol (r)-form","Levalbuterol","Levosalbutamol","Xopenex"],"crossReferences":{"DailyMed":["levalbuterol%20hydrochloride","levalbuterol%20tartrate"],"PubChem":["11111805","11111806","11112645","11113612"],"Wikipedia":["Levosalbutamol"],"drugbank":["DB13139"],"chEBI":["8746"]},"childChemblIds":["CHEMBL3989693","CHEMBL1201061","CHEMBL3989589"],"count":1,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","HP_0025428"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999 and has 1 investigational indication."}
{"id":"CHEMBL1078685","canonicalSmiles":"N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1","inchiKey":"UBVZQGOVTLIHLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOPIROXOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FYX-051","Topiroxostat"],"crossReferences":{"drugbank":["DB01685"]},"count":2,"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["EFO_0009104","EFO_0000401"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1086440","canonicalSmiles":"CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1","inchiKey":"NQPDXQQQCQDHHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLABENDAZOLE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Egaten","Egaten tm"],"synonyms":["EGA230B","NVP-EGA230","Triclabendazole"],"crossReferences":{"DailyMed":["triclabendazole"],"PubChem":["144205784","26719864","26758032","49681760","50085431","85182180"],"Wikipedia":["Triclabendazole"],"drugbank":["DB12245"]},"count":2,"approvedIndications":["EFO_1001342","EFO_1001324"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for helminthiasis and fascioliasis."}
{"id":"CHEMBL1095032","canonicalSmiles":"O=C([C@H](O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1","inchiKey":"GEHAEMCVKDPMKO-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETAXABAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Letaxaban","TAK 442","TAK-442"],"crossReferences":{"drugbank":["DB11984"]},"count":2,"linkedTargets":{"rows":["ENSG00000126218"],"count":1},"linkedDiseases":{"rows":["EFO_0004286","EFO_0005672"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1129","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F","inchiKey":"VSQQQLOSPVPRAZ-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLURIDINE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["T.f.t.","Trifluridine","Triherpine","Viroptic"],"synonyms":["NSC-529182","NSC-75520","Trifluridine","Trifluridine "],"crossReferences":{"DailyMed":["trifluridine"],"PubChem":["131404691","144205964","170464911","26748925","56422883","8139891"],"Wikipedia":["Trifluridine"],"drugbank":["DB00432"],"chEBI":["75179"]},"count":9,"approvedIndications":["EFO_0000616","EFO_0000365","EFO_0005842","EFO_1001888","EFO_1001951"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and has 5 approved and 4 investigational indications."}
{"id":"CHEMBL1162","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"VIKNJXKGJWUCNN-XGXHKTLJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORETHINDRONE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aygestin","Camila","Errin","Heather","Incassia","Jencycla","Menzol","Micronor","Micronor hrt","Nor-qd","Norethidrone","Norethindrone","Noriday","Norlutin","Primolut n","Utovlan"],"synonyms":["Activella","Aygestin","Combipatch","Femhrt","NSC-9564","Norethindrone","Norethisterone","Norlutate","SC-4640"],"crossReferences":{"DailyMed":["norethindrone"],"PubChem":["144204875","144212744","170464683","49647479"],"Wikipedia":["Norethisterone"],"drugbank":["DB00717"],"chEBI":["7627"]},"count":10,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002687","EFO_0001065","EFO_0009006","EFO_0007453","EFO_0003929","Orphanet_1195","EFO_0003843","EFO_0000311","EFO_0004714","EFO_0008520","HP_0100607","EFO_0003047","EFO_0008522","EFO_0003922"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1186230","canonicalSmiles":"O=P(O)(O)[C@@H](NCc1ccccc1)c1ccccc1","inchiKey":"SLMGIUOAZCYKPE-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1186230","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03577"]},"childChemblIds":["CHEMBL454997"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1188395","canonicalSmiles":"NCc1cnc(S)n1[C@H]1CCc2c(F)cc(F)cc2C1","inchiKey":"YZZVIKDAOTXDEB-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEPICASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nepicastat","SYN-117","SYN117"],"crossReferences":{"drugbank":["DB12979"]},"childChemblIds":["CHEMBL536282"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1190262","canonicalSmiles":"CCCCCCCC/N=C(N)/N=C(\\N)NCc1ccc(Cl)c(Cl)c1","inchiKey":"ZZQMUJGZCZTLQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLANEXIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olanexidine"],"childChemblIds":["CHEMBL540531","CHEMBL3989554"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL119888","canonicalSmiles":"O=C(O)c1ccccc1S","inchiKey":"NBOMNTLFRHMDEZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOSALICYLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercapto-Benzoic Acid"],"crossReferences":{"PubChem":["144207109","170465571","855771"],"Wikipedia":["Thiosalicylic_acid"],"drugbank":["DB14026"],"chEBI":["59124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200410","canonicalSmiles":"CNNCc1ccc(C(=O)NC(C)C)cc1.Cl","inchiKey":"DERJYEZSLHIUKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCARBAZINE HYDROCHLORIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1321","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Matulane","Natulan"],"synonyms":["NCI-C 01810","NCI-C-01810","NSC-77213","Procarbazine hydrochloride","RO 4-646711","RO-4-6467 HYDROCHLORIDE","Ro-46467/1"],"crossReferences":{"DailyMed":["procarbazine%20hydrochloride"],"PubChem":["144203990","144212635","170465402","49681829","551000"],"chEBI":["71428"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200434","canonicalSmiles":"C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O","inchiKey":"RLANKEDHRWMNRO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXTRIPHYLLINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL190","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Choledyl","Choledyl sa","Oxtriphylline","Oxtriphylline pediatric","Sabidal"],"synonyms":["Choline theophyllinate","Choline theophylline","Oxtriphylline"],"crossReferences":{"DrugCentral":["4390"],"Wikipedia":["Choline_theophyllinate"],"drugbank":["DB01303"]},"count":1,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000152270","ENSG00000282608","ENSG00000065989","ENSG00000128271","ENSG00000163485","ENSG00000170425","ENSG00000105650","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":10},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and is indicated for airway obstruction."}
{"id":"CHEMBL1200438","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1","inchiKey":"QXHHHPZILQDDPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOCONAZOLE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tioconazole","Trosyl","Tz-3","Vagistat","Vagistat-1"],"synonyms":["Tioconazole","UK-20,349","UK-20349"],"crossReferences":{"PubChem":["144205987","170465343","50112684"],"Wikipedia":["Tioconazole"],"drugbank":["DB01007"],"chEBI":["77898"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1200453","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCCCCO","inchiKey":"NOPFSRXAKWQILS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCOSANOL","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abreva"],"synonyms":["Behenyl alcohol","Docosanol","Lidakol","N-docosanol","NSC-8407"],"crossReferences":{"DailyMed":["docosanol"],"PubChem":["174006877","29215293"],"Wikipedia":["Docosanol"],"drugbank":["DB00632"],"chEBI":["31000"]},"count":1,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for viral disease."}
{"id":"CHEMBL1200470","canonicalSmiles":"COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Na+]","inchiKey":"RYXPMWYHEBGTRV-JIDHJSLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE SODIUM","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201320","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esomeprazole sodium","Nexium","Nexium iv"],"synonyms":["Esomeprazole sodium","H199/18 SODIUM"],"crossReferences":{"DailyMed":["esomeprazole%20sodium"]},"count":3,"approvedIndications":["EFO_0003948","EFO_0004607"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0009454","MONDO_0004247","EFO_0004607","EFO_1000961"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for duodenal ulcer and gastroesophageal reflux disease and has 1 investigational indication."}
{"id":"CHEMBL1200599","canonicalSmiles":"Cl.N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1","inchiKey":"VMIZTXDGZPTKIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFENOXIN HYDROCHLORIDE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201321","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Difenoxin HCl","Difenoxin hydrochloride"],"crossReferences":{"DailyMed":["difenoxin%20hydrochloride"],"chEBI":["59790"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL1200661","canonicalSmiles":"CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)OC(C)C","inchiKey":"XXUPXHKCPIKWLR-JHUOEJJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNOPROSTONE ISOPROPYL","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rescula"],"synonyms":["Isopropyl unoprostone","UF-021","Unoprostone Isopropyl","Unoprostone isopropyl","Unoprostone isopropyl ester"],"crossReferences":{"PubChem":["144207178"],"chEBI":["31731"]},"count":3,"approvedIndications":["EFO_0000516"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for glaucoma and has 2 investigational indications."}
{"id":"CHEMBL1200877","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C","inchiKey":"JWRMHDSINXPDHB-OJAGFMMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMETHASONE PIVALATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Locorten","Locorten-vioform"],"synonyms":["Flumetasone pivalate","Flumethasone pivalate"],"crossReferences":{"PubChem":["56423133","855730"],"chEBI":["31620"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201006","canonicalSmiles":"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1.O=C(O)/C=C\\C(=O)O","inchiKey":"JXYWFNAQESKDNC-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRILAMINE MALEATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL511","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pyrilamine maleate"],"synonyms":["Pyrilamine maleate"],"crossReferences":{"PubChem":["144207712","26747601","26747602","50106737","50106738","50106739","56422415","855902","93576628"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973."}
{"id":"CHEMBL1201227","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1","inchiKey":"SWRUZBWLEWHWRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCRIMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cycrimine"],"crossReferences":{"Wikipedia":["Cycrimine"],"drugbank":["DB00942"],"chEBI":["59692"]},"childChemblIds":["CHEMBL1200828"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201355","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"YRALAIOMGQZKOW-HYAOXDFASA-N","drugType":"Protein","blackBoxWarning":false,"name":"CERULETIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceruletide"],"crossReferences":{"Wikipedia":["Ceruletide"],"drugbank":["DB00403"],"chEBI":["59219"]},"childChemblIds":["CHEMBL1200755"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201580","drugType":"Antibody","blackBoxWarning":true,"name":"ADALIMUMAB","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humira"],"synonyms":["AVT-02","Adalimumab","Adalimumab (genetical recombination)","Adalimumab beta","BI695501","CT-P17","D2E7","FKB-327","FKB327","GP2017","HLX-03","HLX03","LU-200134","LU200134","M923","MSB-11022","MSB11022","ZRC-3197","ZRC3197"],"crossReferences":{"DailyMed":["adalimumab"],"DrugCentral":["4904"],"Wikipedia":["Adalimumab"]},"count":27,"approvedIndications":["EFO_0000729","EFO_0000685","EFO_0003898","EFO_0000676","EFO_0003778","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0004683","EFO_1000710","EFO_0003780","EFO_0008507","EFO_0003778","EFO_0000540","HP_0011868","Orphanet_634","Orphanet_247353","EFO_0002506","EFO_0000676","EFO_0004616","HP_0000999","EFO_1000789","Orphanet_797","EFO_0000685","EFO_1001857","Orphanet_79213","MONDO_0002108","EFO_0003898","EFO_0004236","EFO_0000384","EFO_0002609","EFO_0004229","EFO_1001209","EFO_1001231","MP_0001845","EFO_0000270","EFO_0000706","EFO_0003872"],"count":31},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 6 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201636","drugType":"Enzyme","blackBoxWarning":false,"name":"HYALURONIDASE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amphadase","Hyalase","Hydase","Jalovis","Kinetin","Vitrase","Wydase"],"synonyms":["Hyaluronidase","Hyaluronidases"],"crossReferences":{"DailyMed":["hyaluronidase","hyaluronidase-fihj","hyaluronidase-oysk","hyaluronidase-zzxf"],"DrugCentral":["5033"],"Wikipedia":["Hyaluronidase"]},"count":9,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 9 investigational indications."}
{"id":"CHEMBL1230795","canonicalSmiles":"Nc1ncnc2c1nc(Br)n2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"KVVVTFSHHQCHNZ-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-Bromo-Adenosine Diphosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Bromo-Adenosine Diphosphate"],"crossReferences":{"drugbank":["DB04554"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231160","canonicalSmiles":"NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O","inchiKey":"MPUQHZXIXSTTDU-QXGSTGNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEVONEDISTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN 4924","MLN-4924","MLN-4924003","MLN4924","Pevonedistat"],"crossReferences":{"drugbank":["DB11759"]},"childChemblIds":["CHEMBL2364622"],"count":13,"linkedTargets":{"rows":["ENSG00000144744","ENSG00000159593"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001779","EFO_0000220","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0000588","EFO_0000182","EFO_0001378","EFO_0002617"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL123368","canonicalSmiles":"NS(=O)(=O)c1cccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)c1","inchiKey":"BKDUVKJYBJDZQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123368","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08248"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233797","canonicalSmiles":"COc1ccc2c(c1)CN(C(=O)CCN1CCC(Cc3ccccc3)CC1)CCS2","inchiKey":"KCWGETCFOVJEPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233797","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02929"]},"childChemblIds":["CHEMBL2440857"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233985","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1C","inchiKey":"KPDQZGKJTJRBGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMIFLAVIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lumiflavin"],"crossReferences":{"drugbank":["DB04726"],"chEBI":["43661"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235743","canonicalSmiles":"c1ccc([C@@H]2CO2)cc1","inchiKey":"AWMVMTVKBNGEAK-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235743","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193692"],"drugbank":["DB04499"],"chEBI":["45389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236230","canonicalSmiles":"CO[C@@H](C(=O)N[C@H]1CC[C@@H](O)CNC1=O)[C@H](O)[C@@H](O)[C@H](O)/C=C/C(C)(C)C","inchiKey":"FVBBTOIQETYGOA-SDNORSGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236230","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255654","canonicalSmiles":"CCCCNc1ccc(C(=O)OCCN(C)C)cc1.Cl","inchiKey":"PPWHTZKZQNXVAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACAINE HYDROCHLORIDE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL698","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anethaine","Locan","Pontocaine hydrochloride","Tetracaine hydrochloride"],"synonyms":["Amethocaine hydrochloride","Tetracaine hydrochloride"],"crossReferences":{"DailyMed":["tetracaine%20hydrochloride"],"PubChem":["11533049","144203841","170465190","26747689","26747690","50107143","50107144","50107145","85273695"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0009540"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2016."}
{"id":"CHEMBL1256978","canonicalSmiles":"Cn1c(=O)c(C(=O)NCCO)c(O)c2ncc(Cc3ccc(F)cc3)cc21","inchiKey":"QWLNINWUBHHOLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-364735","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK364735","Gsk-364735","S-364735"],"crossReferences":{"drugbank":["DB13119"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1257032","canonicalSmiles":"Cc1cc(C)c(Nc2ccnc(Nc3ccc([14C]#N)cc3)n2)c(C)c1","inchiKey":"ILAYIAGXTHKHNT-HVRMQOCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[14C]DAPIVIRINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL70663","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dapivirine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1277072","canonicalSmiles":"Cc1c(/C=C2\\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)N(C[C@H](O)CN1CCOCC1)CCC2","inchiKey":"MCTXSDCWFQAGFS-UEXNTNOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HENATINIB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13019"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1290","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1","inchiKey":"KQXKVJAGOJTNJS-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENBUTOLOL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levatol","Penbutolol"],"crossReferences":{"Wikipedia":["Penbutolol"],"drugbank":["DB01359"],"chEBI":["7954"]},"childChemblIds":["CHEMBL1200363","CHEMBL2361370"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1366933","canonicalSmiles":"CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1","inchiKey":"RONZAEMNMFQXRA-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESMIRTAZAPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Esmirtazapine","ORG-44-20"],"crossReferences":{"PubChem":["11114267"],"drugbank":["DB06678"]},"childChemblIds":["CHEMBL2107339"],"count":1,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000102468","ENSG00000196639","ENSG00000150594","ENSG00000147246"],"count":6},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1464","canonicalSmiles":"CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O","inchiKey":"PJVWKTKQMONHTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"WARFARIN","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-59813","Warfarin"],"crossReferences":{"DailyMed":["warfarin%20sodium"],"PubChem":["144206736","144209380","144210849","174006926","26748308","26754489"],"Wikipedia":["Warfarin"],"drugbank":["DB00682"],"chEBI":["87732"]},"childChemblIds":["CHEMBL1200879","CHEMBL1200772"],"count":52,"approvedIndications":["MONDO_0000831","HP_0004419"],"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0001361","EFO_0003777","HP_0002239","EFO_0007401","EFO_0000275","MONDO_0002009","EFO_0000249","EFO_0000266","EFO_0003914","EFO_0002506","HP_0001871","EFO_0009952","EFO_0000676","EFO_1002032","EFO_1000059","EFO_0000400","EFO_0002618","EFO_0002689","MONDO_0005149","EFO_0006911","EFO_0001642","EFO_0002508","EFO_0004286","HP_0001873","MONDO_0008315","EFO_0000384","EFO_0001422","MP_0001914","MONDO_0000831","EFO_0009557","EFO_0000574","EFO_0003907","EFO_0001360","EFO_0005672","HP_0004418","HP_0000726","EFO_0000768","MONDO_0002679","EFO_0000274","EFO_0002950","EFO_0004211","EFO_0003911","EFO_0000474","Orphanet_325","EFO_1001375","EFO_0003144","EFO_0000712","EFO_1001161","HP_0004419","HP_0004936","EFO_0000616","EFO_0000685","HP_0002140","EFO_0003875","EFO_0001645","HP_0001655","EFO_0003929","EFO_0004277","EFO_0000319","EFO_0000311","HP_0001907","EFO_0003764","EFO_0010680","EFO_0003827","EFO_1000781","EFO_0000612"],"count":67},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for thrombotic disease and recurrent thrombophlebitis and has 50 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL14882","canonicalSmiles":"Nc1ccc2c(=O)[nH][nH]c(=O)c2c1","inchiKey":"HUDPLKWXRLNSPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL14882","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89850458"],"drugbank":["DB02041"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1506225","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.O=[N+]([O-])[O-]","inchiKey":"BSQIVYOSLFLSGE-RAFJPFSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1506225","maximumClinicalTrialPhase":0,"parentId":"CHEMBL376897","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855779"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1562610","canonicalSmiles":"Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]","inchiKey":"QHJLLDJTVQAFAN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"MECLOFENAMATE SODIUM","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL509","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Meclodium","Meclofenamate sodium","Meclomen"],"synonyms":["CL-583.NA SALT","Meclofenamate sodium"],"crossReferences":{"DailyMed":["meclofenamate%20sodium"],"PubChem":["11112978","144204315","170464886","85273783"],"chEBI":["76232"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1572751","canonicalSmiles":"Cl.O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12","inchiKey":"CEUMONXVSJOJIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1572751","maximumClinicalTrialPhase":0,"parentId":"CHEMBL146095","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204229","170465943","56463370"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL159659","canonicalSmiles":"CCC(=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"USSIQXCVUWKGNF-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMETHADONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levomethadone"],"crossReferences":{"drugbank":["DB13515"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL16","canonicalSmiles":"O=C1N=C(O)NC1(c1ccccc1)c1ccccc1","inchiKey":"CXOFVDLJLONNDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PHENYTOIN","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilabid","Dilantin","Dilantin-125","Dilantin-30","Diphenylhydantoin","Hydantol","Phentytoin","Phenytoin"],"synonyms":["Diphenylhydantoin","NSC-8722","Phenytek","Phenytex","Phenytoin","SM-88 COMPONENT PHENYTOIN"],"crossReferences":{"DailyMed":["phenytoin","phenytoin%20sodium"],"PubChem":["11111069","11532994","124879886","124886706","144204412","144209497","144210601","170464785","17389903","26753026","26753027","26753028","50106148","56423134","85230999","90340679","90341165"],"TG-GATEs":["26"],"Wikipedia":["Phenytoin"],"drugbank":["DB00252"],"chEBI":["8107"]},"childChemblIds":["CHEMBL3274483","CHEMBL553532","CHEMBL3786353","CHEMBL1611"],"count":16,"approvedIndications":["EFO_0000474","HP_0001250"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["HP_0002069","EFO_0002618","EFO_0007405","EFO_0002610","Orphanet_232","HP_0000726","HP_0001250","EFO_0000621","EFO_0000565","EFO_0009562","EFO_0000546","EFO_0000474","MONDO_0002050","EFO_1001996","EFO_0000270","EFO_0000574","EFO_0004272","EFO_0005230","EFO_0000692"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for epilepsy and seizure and has 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1615784","canonicalSmiles":"CCOCCP(CCOCC)CCP(CCOCC)CCOCC","inchiKey":"QCWJONLQSHEGEJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETROFOSMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-53","P53","Tetrofosmin"],"crossReferences":{"drugbank":["DB11180"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1623738","canonicalSmiles":"COc1ccc(CN(CCN(C)C)c2ncccn2)cc1","inchiKey":"GULNIHOSWFYMRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THONZYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thonzylamine"],"crossReferences":{"Wikipedia":["Thonzylamine"],"drugbank":["DB11235"]},"childChemblIds":["CHEMBL1529802"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1643","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1","inchiKey":"IWUCXVSUMQZMFG-AFCXAGJDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RIBAVIRIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Copegus","Rebetol","Ribapak","Ribasphere","Ribavarin","Ribavirin","Ribofluranosyl Carboxamide","Tribavirin","Viramid","Virazid","Virazole"],"synonyms":["NSC-163039","Ribavirin","SCH 18908","SCH-18908","Tribavirin"],"crossReferences":{"DailyMed":["ribavirin"],"PubChem":["144203810","144208165","170464657","17389529","50105410","50105411","50105412","50105413","8139972","90341426"],"Wikipedia":["Ribavirin"],"drugbank":["DB00811"],"chEBI":["63580"]},"count":21,"approvedIndications":["EFO_0001422","EFO_0004220","EFO_0000763"],"linkedTargets":{"rows":["ENSG00000106348"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","EFO_1001413","EFO_0007304","EFO_0007303","EFO_0007294","MONDO_0002050","EFO_0000544","Orphanet_68364","EFO_0006890","EFO_0000182","EFO_0004272","EFO_0007332","EFO_0003047","EFO_0007243","EFO_0007299","HP_0012115","EFO_0000616","EFO_0000694","EFO_0001642","EFO_0000222","EFO_0004197","HP_0001873","EFO_0004239","EFO_0001422","EFO_0004220","EFO_0007306","MONDO_0100096","EFO_0000764","EFO_0001421","EFO_0007328","EFO_0000763"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1683","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"BMCQMVFGOVHVNG-TUFAYURCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE BUTYRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hydrocortisone butyrate","Locoid","Locoid c","Locoid crelo","Locoid lipocream"],"synonyms":["Hydrocortisone 17-butyrate","Hydrocortisone butyrate"],"crossReferences":{"DailyMed":["hydrocortisone%20butyrate"],"PubChem":["11533027","144204950","170465456","56422894"],"Wikipedia":["Hydrocortisone_17-butyrate"],"drugbank":["DB14540"],"chEBI":["31674"]},"count":2,"approvedIndications":["EFO_0000274"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001034","EFO_1001494","EFO_0009462","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for atopic eczema and has 1 investigational indication."}
{"id":"CHEMBL1695","canonicalSmiles":"Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C.Cl","inchiKey":"YUKARLAABCGMCN-PKLMIRHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAGABINE HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1027","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabitril","Tiagabine hydrochloride"],"synonyms":["ABBOTT-70569 HYDROCHLORIDE","ABBOTT-70569.1","ABBOTT-70569.HCL","ABBOTT-705691","ABT-569","Abbott-70569","Abbott-70569.1","NNC-05-0328","NNC-050328","NO-05-0328","NO-050328","Tiagabine hydrochloride"],"crossReferences":{"DailyMed":["tiagabine%20hydrochloride"],"PubChem":["144205798","170465153","49681547"],"chEBI":["85388"]},"count":1,"linkedTargets":{"rows":["ENSG00000157103"],"count":1},"linkedDiseases":{"rows":["EFO_1001892","EFO_1001917","EFO_0005230"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication."}
{"id":"CHEMBL1742461","canonicalSmiles":"O=C(C[S+]([O-])Cc1ccco1)NC/C=C\\COc1cc(CN2CCCCC2)ccn1","inchiKey":"KMZQAVXSMUKBPD-DJWKRKHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAFUTIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lafutidine"],"crossReferences":{"PubChem":["144205732","170465978"],"drugbank":["DB12770"]},"count":4,"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398","EFO_0009454","EFO_0000337"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743058","drugType":"Antibody","blackBoxWarning":false,"name":"PONEZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04360365","Ponezumab","RN-1219"],"count":2,"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["EFO_0006790","EFO_0000249"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1760","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(O)cc(O)c1","inchiKey":"XWTYSIMOBUGWOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TERBUTALINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Brethaire","Brethine","Bricanyl","Terbutaline"],"crossReferences":{"DailyMed":["terbutaline%20sulfate"],"PubChem":["90341646"],"Wikipedia":["Terbutaline"],"drugbank":["DB00871"],"chEBI":["9449"]},"childChemblIds":["CHEMBL1315867","CHEMBL1160544"],"count":5,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0006536","EFO_0000270","EFO_0008590","EFO_0001359","EFO_0003144","EFO_0000341","EFO_0003843"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for airway obstruction and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1765293","canonicalSmiles":"C=C(C)CNc1ccc(C(C)C(=O)O)cc1","inchiKey":"FPHLBGOJWPEVME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMINOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alminoprofen"],"crossReferences":{"Wikipedia":["Alminoprofen"],"drugbank":["DB13314"],"chEBI":["31190"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1788403","canonicalSmiles":"C=CCC1=C(C)C(OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O","inchiKey":"ZCVAOQKBXKSDMS-AQYZNVCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIOALLETHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bioallethrin"],"crossReferences":{"chEBI":["39118"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1796997","canonicalSmiles":"[He]","inchiKey":"SWQJXJOGLNCZEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HELIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-939","E939","Helium","INS NO.939","INS-939"],"crossReferences":{"drugbank":["DB09155"],"chEBI":["30217"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 2 investigational indications."}
{"id":"CHEMBL187709","canonicalSmiles":"CCN(CC)CCOc1ccc(C(O)(Cc2ccc(Cl)cc2)c2ccc(C)cc2)cc1","inchiKey":"SYHDSBBKRLVLFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPARANOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," United States"],"classes":["Dermatological toxicity"," Opthalmic toxicity"],"year":1962},"tradeNames":[],"synonyms":["Triparanol"],"crossReferences":{"PubChem":["144205821","170466640","29217665","50111719"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France and  United States initially in 1962 due to Dermatological toxicity and  Opthalmic toxicity."}
{"id":"CHEMBL1908373","canonicalSmiles":"CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1","inchiKey":"IEXUMDBQLIVNHZ-YOUGDJEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONAPRISTONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Onapristone","ZK-299","ZK-98299","ZK299","Zk-98299"],"crossReferences":{"drugbank":["DB12637"]},"count":3,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000196","MONDO_0007254"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL193233","canonicalSmiles":"COc1ccc(-c2ccccc2)cc1N1CC(=O)NS1(=O)=O","inchiKey":"IGXKSKWHHHYBFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL193233","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08591"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2012520","canonicalSmiles":"CC(C)(Cc1ccc(Oc2ccc(C(N)=O)cn2)cc1)NC[C@H](O)COc1cccc2[nH]c3ccccc3c12","inchiKey":"RBSGUQYXRDKPAE-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY377604","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-377604","Ly377604"],"crossReferences":{"drugbank":["DB12858"]},"childChemblIds":["CHEMBL2012522","CHEMBL2012521"],"count":1,"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL206109","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cc(OCC3CCCCC3)nc3ncnn23)cc1","inchiKey":"NMAZGYDYIYLSLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL206109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07685"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2063705","canonicalSmiles":"CNC(=O)C[C@@H]1NC(=O)c2csc(n2)-c2ccc(-c3nc(N(CCCCC(=O)O)C(=O)O[C@H]4CC[C@H](C(=O)O)CC4)cs3)nc2-c2csc(n2)-c2csc(n2)[C@H]([C@@H](O)c2ccccc2)NC(=O)CNC(=O)c2nc(sc2COC)[C@H](C(C)C)NC(=O)c2nc1sc2C","inchiKey":"GNLYKLDXQZHYTR-LMOGNUDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LFF-571","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.333.591A","LFF571","Lff-571"],"crossReferences":{"drugbank":["DB13013"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2095207","canonicalSmiles":"C[N+](C)([11CH3])CCO.[Cl-]","inchiKey":"SGMZJAMFUVOLNK-ULWFUOSBSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE C-11","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL282468","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Choline c-11"],"synonyms":["Choline c-11"],"crossReferences":{"drugbank":["DB09277"],"chEBI":["72321"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and has 1 investigational indication."}
{"id":"CHEMBL2103837","canonicalSmiles":"O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1","inchiKey":"TXEIIPDJKFWEEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFAMIDIS","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vyndamax","Vyndaqel"],"synonyms":["FX-1005","FX-1006","FX1006","Tafamidis"],"crossReferences":{"DailyMed":["tafamidis","tafamidis%20meglumine"],"drugbank":["DB11644"],"chEBI":["78538"]},"childChemblIds":["CHEMBL2105675"],"count":4,"approvedIndications":["EFO_0000318","EFO_1001875","Orphanet_85443"],"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_0009562","EFO_0000318","EFO_1001875","Orphanet_271861","Orphanet_85447","Orphanet_85443"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL2104114","canonicalSmiles":"CN(CCOP(=O)(O)O)C(=N)N","inchiKey":"FOIPWTMKYXWFGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CREATINOLFOSFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cop","Creatinolfosfate"],"crossReferences":{"drugbank":["DB13071"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104523","canonicalSmiles":"CCOc1cc(N)c([N+](=O)[O-])cc1C(=O)NC1CCN(CC2CC=CCC2)CC1","inchiKey":"ZDLBNXXKDMLZMF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINITAPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinitapride"],"crossReferences":{"drugbank":["DB08810"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104537","canonicalSmiles":"COc1cc(C(=O)OC(COCCC(C)C)CN2CCOCC2)cc(OC)c1OC","inchiKey":"YOKPRDAUBGOISU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOPROXAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Dermatological toxicity"],"year":1970},"tradeNames":[],"synonyms":["Amoproxan","CERM 730"],"crossReferences":{"PubChem":["144206871"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1970 due to Dermatological toxicity."}
{"id":"CHEMBL2105318","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C(O)=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1","inchiKey":"KHKDIUPVDIEHAH-KXLSUQFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXABOLONE CIPIONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FI 5852","Oxabolone cipionate"],"crossReferences":{"PubChem":["144206313"],"drugbank":["DB13185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105345","canonicalSmiles":"CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1","inchiKey":"KEJXLQUPYHWCNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANIDID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Immune system toxicity"],"year":1983},"tradeNames":["Epontol"],"synonyms":["BAYER 1420","FBA 1420","Propanidid","TH-2180","WH 5668"],"crossReferences":{"PubChem":["144206858"],"drugbank":["DB13234"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom  in 1983 due to Immune system toxicity."}
{"id":"CHEMBL2105690","canonicalSmiles":"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1.Cl.Cl","inchiKey":"WDVGRPCSLPVWKC-VROLVAQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVITOCLAX DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL443684","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-855071.3","Navitoclax dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105722","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"KZUIYQJTUIACIG-YBZCJVABSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOMEGESTROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nomegestrol"],"crossReferences":{"drugbank":["DB11636"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2105762","canonicalSmiles":"CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2","inchiKey":"MKMPWKUAHLTIBJ-ISTRZQFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMARIGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-3102","Omarigliptin"],"crossReferences":{"drugbank":["DB11992"]},"childChemblIds":["CHEMBL3234203"],"count":2,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105763","canonicalSmiles":"Cn1cc(CNCC2CCN(c3ncc(C(=O)NO)cn3)CC2)c2ccccc21","inchiKey":"PAWIYAYFNXQGAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUISINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ 26481585","JNJ-26481585","Quisinostat"],"crossReferences":{"drugbank":["DB12985"]},"childChemblIds":["CHEMBL3039527"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2106119","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Ca+2]","inchiKey":"NEEHYRZPVYRGPP-IYEMJOQQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLUCONATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium gluconate in sodium chloride","Calglucon","H-f antidote"],"synonyms":["Calcium gluconate","Calcium gluconate anhydrous","E-578","INS NO.578","INS-578"],"crossReferences":{"DailyMed":["calcium%20gluconate"],"DrugCentral":["4348"],"drugbank":["DB11126"]},"count":5,"approvedIndications":["HP_0002901"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for hypocalcemia and has 4 investigational indications."}
{"id":"CHEMBL2106780","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1.NCCO[N+](=O)[O-]","inchiKey":"HPPBBWMYZVALRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ITRAMIN TOSYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL609980","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Itramin tosilate","Itramin tosylate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107123","canonicalSmiles":"N[C@@H](CCC(=O)[O-])C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-].[Na+].[Na+]","inchiKey":"GDLPAGOVHZLZEK-JBUFHSOLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"OGLUFANIDE DISODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2111029","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glufanide disodium","IM-862","IM862","Oglufanide disodium"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107253","canonicalSmiles":"COc1cc([N-]S(=O)(=O)c2ccc(N)cc2)nc(OC)n1.[Na+]","inchiKey":"DQDZQHMCPDUUPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIMETHOXINE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL62193","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Sulfadimethoxine sodium"],"crossReferences":{"chEBI":["81722"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL2107288","canonicalSmiles":"O=C(O)c1ccccc1O.OCCN(CCO)CCO","inchiKey":"UEVAMYPIMMOEFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLAMINE SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trolamine salicylate"],"crossReferences":{"DrugCentral":["4442"],"PubChem":["144208282"],"drugbank":["DB11079"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107486","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(SC3CN(C4=NCCS4)C3)[C@H](C)[C@H]12","inchiKey":"SNUDIPVBUUXCDG-QHSBEEBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEBIPENEM PIVOXIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Orapenem"],"synonyms":["L-084","LJC 11,084","LJC 11084","LJC-11084","ME-1211","ME1211","TBPM-PI","Tebipenem pivoxil"],"childChemblIds":["CHEMBL4297677"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108342","drugType":"Antibody","blackBoxWarning":false,"name":"GEMTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gemtuzumab"],"count":1,"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108567","drugType":"Antibody","blackBoxWarning":false,"name":"TANEZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04383119","PF-4383119","RN-624","RN624","Tanezumab"],"count":11,"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0002506","HP_0012532","EFO_0001065","EFO_1000786","EFO_0004616","EFO_0006510","HP_0003419","EFO_1000869","EFO_0003830","EFO_0000342","EFO_0003843"],"count":12},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL2108576","drugType":"Antibody","blackBoxWarning":false,"name":"BAPINEUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3D-6","AAB-001","AAB-001, Humanized 3D-6 Monoclonal Antibody","Bapineuzumab","HUMANIZED 3D-6 MONOCLONAL ANTIBODY"],"count":1,"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108603","drugType":"Protein","blackBoxWarning":false,"name":"HEMOGLOBIN GLUTAMER-250 (BOVINE)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hemopure"],"synonyms":["HBOC-201","Hemoglobin glutamer-250 (bovine)"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108683","drugType":"Unknown","blackBoxWarning":false,"name":"ENTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cblb502"],"synonyms":["CBLB-502","CBLB502","Entolimod"],"count":3,"linkedTargets":{"rows":["ENSG00000187554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003890","EFO_1001951"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109583","drugType":"Antibody","blackBoxWarning":false,"name":"F16IL2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F16IL2","F16il2"],"count":3,"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["EFO_1001471","MONDO_0007254","EFO_0000222"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109648","drugType":"Antibody","blackBoxWarning":false,"name":"REGN-846","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-846","SAR302352"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110686","canonicalSmiles":"CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O","inchiKey":"SDMBRCRVFFHJKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCABENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gemcabene"],"crossReferences":{"drugbank":["DB05123"]},"childChemblIds":["CHEMBL2105057"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110727","canonicalSmiles":"CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1","inchiKey":"PNDKCRDVVKJPKG-WHERJAGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENICRIVIROC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenicriviroc","TAK-652","TBR-652"],"crossReferences":{"drugbank":["DB11758"]},"childChemblIds":["CHEMBL2105686"],"count":7,"linkedTargets":{"rows":["ENSG00000160791","ENSG00000121807"],"count":2},"linkedDiseases":{"rows":["EFO_0004268","MONDO_0100096","EFO_0000544","EFO_0003095","EFO_0000764","EFO_0001421","EFO_0000180","EFO_1001249"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2111088","canonicalSmiles":"COC(=O)Nc1nc2cc(Sc3ccc(NC(=O)[C@H](C)N)cc3)ccc2[nH]1","inchiKey":"GAOHLWCIAJNSEE-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DENIBULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denibulin"],"crossReferences":{"drugbank":["DB05932"]},"childChemblIds":["CHEMBL2107329"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2136050","canonicalSmiles":"CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1.Cl.Cl","inchiKey":"RFXGEKWBTCMDAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2136050","maximumClinicalTrialPhase":0,"parentId":"CHEMBL258940","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205549","170466895"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2180604","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1","inchiKey":"DZFZXPPHBWCXPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-593","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK 593","TAK-593","Tak-593"],"crossReferences":{"drugbank":["DB13093"]},"count":1,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721"],"count":5},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2216870","canonicalSmiles":"CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1","inchiKey":"IFSDAJWBUCMOAH-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IDELALISIB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zydelig"],"synonyms":["CAL-101","GS-1101","GS-11CAL-101","Idelalisib"],"crossReferences":{"DailyMed":["idelalisib"],"drugbank":["DB09054"],"chEBI":["82701"]},"count":17,"approvedIndications":["EFO_0000616","EFO_0000096","EFO_0000095","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0005854","EFO_0000616","MONDO_0044903","EFO_0000220","EFO_0001642","EFO_0000403","EFO_0000222","EFO_1001875","EFO_1001469","EFO_0000311","EFO_0000096","EFO_0000095","EFO_0002517","EFO_0000574","MONDO_0018906","EFO_0000183","EFO_0001378"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 4 approved and 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2218917","canonicalSmiles":"CC1OC2(CS1)CN1CCC2CC1.Cl.O","inchiKey":"JKJRNPOQQPBPOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEVIMELINE HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL168815","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cevimeline","Cevimeline hydrochloride","Evoxac"],"synonyms":["AF-102B","AF102B","Cevimeline hydrochloride","Cevimeline hydrochloride hemihydrate","Cevimeline hydrochloride hydrate","FKS-508","SND-5008","SNI-2011","SNK-508"],"crossReferences":{"DailyMed":["cevimeline%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL2251610","canonicalSmiles":"CCOC(=O)c1ccccc1O","inchiKey":"GYCKQBWUSACYIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206317","144207003","170466844"],"drugbank":["DB15576"],"chEBI":["88839"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230158","canonicalSmiles":"CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1","inchiKey":"JWHYSEDOYMYMNM-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELADELPAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MBX-8025","Mbx-8025","RWJ-800025","Seladelpar"],"crossReferences":{"drugbank":["DB12390"]},"childChemblIds":["CHEMBL3989960"],"count":6,"linkedTargets":{"rows":["ENSG00000112033"],"count":1},"linkedDiseases":{"rows":["EFO_0004268","EFO_0001421","EFO_1001249","Orphanet_391665","EFO_0003774","EFO_1001486"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL230354","canonicalSmiles":"CC(=O)Nc1cccc(Nc2nc(Nc3ccccc3)n3ncc(C#N)c3n2)c1","inchiKey":"QVKXQLGRDOMAGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230354","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08362"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23293","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CSc1ccccc1C(=O)O","inchiKey":"WUILNKCFCLNXOK-CFBAGHHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALIRASIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FTS","Salirasib"],"crossReferences":{"PubChem":["11111197","50106301","50106302","520931","85231054"],"drugbank":["DB12681"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2357792","canonicalSmiles":"CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H](C2[C@H]5O)N3[C@@H]1O","inchiKey":"CJDRUOGAGYHKKD-HEFSZTOGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2357792","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204279"],"drugbank":["DB01426"],"chEBI":["28462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL236720","canonicalSmiles":"COCc1cc(O)cc2c1O[C@@H](c1ccc(O)cc1)[C@H]1CC(F)(F)C[C@@H]21","inchiKey":"GPFRMIHXGMVMGF-BZSNNMDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07036"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL246600","canonicalSmiles":"COc1ccc(C[C@@H](O)c2cc(OC)c(OC)c(OC)c2)cc1O","inchiKey":"LGZKGOGODCLQHG-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COMBRETASTATIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Combretastatin","NSC-348103"],"crossReferences":{"drugbank":["DB12596"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL253978","canonicalSmiles":"Cc1scc2c1N(C(=O)CN1CCN(C)CC1)c1ccccc1NC2=O","inchiKey":"VSWPGAIWKHPTKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELENZEPINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Telenzepine"],"crossReferences":{"PubChem":["104171244","11111843","11111844","11113930","11532931","144203825","170466639","26752083","90341323"],"Wikipedia":["Telenzepine"]},"childChemblIds":["CHEMBL1256762","CHEMBL1257109"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL256997","canonicalSmiles":"O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1","inchiKey":"OOUGLTULBSNHNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATALUREN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124"],"crossReferences":{"PubChem":["144206184","170466862","85852879","87334013","99460885"],"Wikipedia":["Ataluren"],"drugbank":["DB05016"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL260829","canonicalSmiles":"Cc1cccc(C)c1NC(=O)CN1CCCC1=O","inchiKey":"NGHTXZCKLWZPGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEFIRACETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nefiracetam"],"crossReferences":{"PubChem":["144207070","144209114","144213342","170466286","174007185","90340767"],"Wikipedia":["Nefiracetam"],"drugbank":["DB13082"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL262075","canonicalSmiles":"CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1","inchiKey":"CBIAWPMZSFFRGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIPLON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL-285489","Indiplon","NBI-34060"],"crossReferences":{"PubChem":["174006212"],"Wikipedia":["Indiplon"],"drugbank":["DB12590"]},"count":2,"linkedTargets":{"rows":["ENSG00000022355"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL28","canonicalSmiles":"O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12","inchiKey":"KZNIFHPLKGYRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-83244"],"crossReferences":{"PubChem":["11110728","11110729","11113975","121464","124879148","124879150","124879152","124879154","124879155","144208740","144213201","17389511","174006549","26747161","26747162","26752115","26752116","46500336","50104771","50104772","50104773","50114379","50114380","85230903","90341029"],"Wikipedia":["Apigenin"],"drugbank":["DB07352"],"chEBI":["18388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28198","canonicalSmiles":"CCC(=O)N(c1ccccc1)[C@@]1(C(=O)OC)CCN(CCc2ccccc2)C[C@H]1C","inchiKey":"IMYHGORQCPYVBZ-NLFFAJNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFENTANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Lofentanil"],"drugbank":["DB09174"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284362","canonicalSmiles":"CCc1ccc(NC(=O)P(=O)(O)O)cc1","inchiKey":"KGNSYMGWPCEFDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[(4-Ethylphenyl)Amino]Carbonylphosphonic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[(4-Ethylphenyl)Amino]Carbonylphosphonic Acid"],"crossReferences":{"drugbank":["DB03628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288470","canonicalSmiles":"Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C","inchiKey":"RMMXTBMQSGEXHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOPYRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"],"classes":["Hematological toxicity"],"year":1970},"tradeNames":[],"synonyms":["Amidopyrine","Aminophenazone","Aminopyrine"],"crossReferences":{"PubChem":["104171274","11112141","144203884","144208742","144213147","170465863","17389912","56463351"],"Wikipedia":["Aminophenazone"],"drugbank":["DB01424"],"chEBI":["160246"]},"childChemblIds":["CHEMBL2104635"],"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain. It was withdrawn in United Kingdom,  United States,  Germany and  France initially in 1970 due to Hematological toxicity."}
{"id":"CHEMBL291747","canonicalSmiles":"C[C@@H](O)[C@H](N)C(=O)O","inchiKey":"AYFVYJQAPQTCCC-GBXIJSLDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THREONINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-threonine","Threonine"],"crossReferences":{"PubChem":["144205707","170465476"],"Wikipedia":["Threonine"],"drugbank":["DB00156"],"chEBI":["16857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292268","canonicalSmiles":"Cn1cnc(N)c2ncnc1-2","inchiKey":"FSASIHFSFGAIJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLADENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04104"],"chEBI":["38635"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL293034","canonicalSmiles":"CN1C(=O)C(=O)c2cc(S(=O)(=O)N3CCC[C@H]3COc3ccccc3)ccc21","inchiKey":"PFAYCUAUBOGVDX-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293034","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08213"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039503","canonicalSmiles":"CC(C)(C)C#Cc1cc(N(C(=O)[C@H]2CC[C@H](C)CC2)[C@H]2CC[C@H](O)CC2)c(C(=O)O)s1","inchiKey":"WPMJNLCLKAKMLA-VVPTUSLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMIBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lomibuvir","VX-222"],"crossReferences":{"drugbank":["DB11954"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3039515","canonicalSmiles":"CCCCC1(CCCC)CN(c2ccccc2)c2cc(SC)c(OCC(=O)N[C@@H](C(=O)NCC(=O)O)c3ccccc3)cc2S(=O)(=O)C1","inchiKey":"XFLQIRAKKLNXRQ-UUWRZZSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELOBIXIBAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-3309","A3309","AZD-7806","AZD7806","Elobixibat"],"crossReferences":{"drugbank":["DB12486"]},"count":3,"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["HP_0012450","EFO_1001249","HP_0002019","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3039533","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1C[C@H]1CCCCCc1nc3ccc(OC)cc3nc1O2)C(=O)NS(=O)(=O)C1CC1.O","inchiKey":"RXSARIJMSJWJLZ-CIAYNJNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRAZOPREVIR","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2063090","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Grazoprevir"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL3125317","canonicalSmiles":"[2H]C([2H])(C)Oc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1","inchiKey":"JVHXJTBJCFBINQ-IYTCCRDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3125317","maximumClinicalTrialPhase":0,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL313302","canonicalSmiles":"O=C1C=C(N2CC2)C(=O)C(N2CC2)=C1N1CC1","inchiKey":"PXSOHRWMIRDKMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAZIQUONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAYER 3231","RIKER 601","Teib","Triaziquone","Triethyleneiminobenzoquinone"],"crossReferences":{"drugbank":["DB13304"],"chEBI":["27090"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137351","drugType":"Antibody","blackBoxWarning":false,"name":"ABRILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 181","AMG-181","Abrilumab","MEDI-7183","MEDI7183"],"count":2,"linkedTargets":{"rows":["ENSG00000115232","ENSG00000139626"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000384"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL329137","canonicalSmiles":"O=P(O)(O)O[C@H]1[C@@H](O)[C@@H](OP(=O)(O)O)[C@H](O)[C@@H](O)[C@@H]1OP(=O)(O)O","inchiKey":"MMWCIQZXVOZEGG-MLQGYMEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329137","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01729"],"chEBI":["18228"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301607","canonicalSmiles":"O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1","inchiKey":"RIJLVEAXPNLDTC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILGOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filgotinib","G-146034","G146034","GLPG0634","GS-6034 FREE BASE","Glpg-0634"],"crossReferences":{"drugbank":["DB14845"]},"childChemblIds":["CHEMBL3301602","CHEMBL4298167"],"count":11,"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000729","EFO_0000685","EFO_0003086","EFO_1001231","EFO_0002690","EFO_0003898","EFO_0003778","EFO_0000384","EFO_0003767","EFO_0000699","EFO_0005629"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL3301627","canonicalSmiles":"CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2cccc(S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)c2)C1.Cl.Cl","inchiKey":"VFRAXTZDILCRKY-OWRGXFNZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENAPANOR HYDROCHLORIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3304485","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ibsrela"],"synonyms":["AZD-1722 HYDROCHLORIDE","AZD1722","AZD1722 hydrochloride","RDX-5791","RDX5791","Tenapanor hydrochloride"],"crossReferences":{"DailyMed":["tenapanor%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0000555"],"linkedTargets":{"rows":["ENSG00000066230"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0003884","HP_0002905"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for irritable bowel syndrome and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3301669","canonicalSmiles":"CN[C@H]1C(=O)N[C@@H]2Cc3ccc(cc3)Oc3cc4cc(c3O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3NC(=O)CCCCCCCCC(C)C)Oc3ccc(cc3Cl)[C@@H](O)[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(cc(O)c2Cl)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@@H](C(=O)NCCCN(C)C)NC3=O","inchiKey":"KGPGQDLTDHGEGT-SZUNQUCBSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"DALBAVANCIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-A-1","BI-397","BI397","Dalbavancin","MDL 64,397","MDL-64397","VER-001","VER001","VERO001"],"crossReferences":{"DailyMed":["dalbavancin%20hydrochloride"],"chEBI":["82721"]},"childChemblIds":["CHEMBL3301650"],"count":8,"approvedIndications":["EFO_0000771"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for bacterial disease and has 7 investigational indications."}
{"id":"CHEMBL3545114","drugType":"Small molecule","blackBoxWarning":false,"name":"KD3010","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kd3010"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545153","drugType":"Small molecule","blackBoxWarning":false,"name":"DE-104","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["De-104"],"count":2,"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545226","drugType":"Small molecule","blackBoxWarning":false,"name":"ACUMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acumapimod","Bct-197"],"count":1,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545286","drugType":"Small molecule","blackBoxWarning":false,"name":"CCX140","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCX140","CCX140-B","Ccx140"],"count":3,"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","EFO_0004236","EFO_0001360"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545373","drugType":"Antibody","blackBoxWarning":false,"name":"ENOBLITUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enoblituzumab","Inc.","MGA-271","MGA271","MacroGenics"],"count":3,"linkedTargets":{"rows":["ENSG00000103855"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","EFO_0000181","MONDO_0008315"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL364804","canonicalSmiles":"CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1","inchiKey":"NXMZBNYLCVTRGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW-406381","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gw 406381","Gw-406381","Gw406381"],"crossReferences":{"drugbank":["DB12009"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3655762","canonicalSmiles":"CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O","inchiKey":"DLPIYBKBHMZCJI-WBVHZDCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3655762","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15425"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707298","canonicalSmiles":"[Mg+2].[O-][O-]","inchiKey":"SPAGIJMPHSUYSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM PEROXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium peroxide"],"crossReferences":{"drugbank":["DB13486"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707355","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD8108","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd8108"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707375","canonicalSmiles":"CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F","inchiKey":"JVCPIJKPAKAIIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMISELIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2240442","Amiselimod"],"childChemblIds":["CHEMBL3707374"],"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["EFO_0002690","EFO_0000676","EFO_0003929","EFO_0000384","EFO_0003767"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3707381","drugType":"Gene","blackBoxWarning":false,"name":"OFRANERGENE OBADENOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ofranergene obadenovec","VB-111"],"count":4,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707404","drugType":"Antibody","blackBoxWarning":false,"name":"LUMRETUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lumretuzumab","RG-7116","RG7116","RO-5479599","RO5479599"],"count":3,"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0003060"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707407","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"CALCIUM ALGINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium alginate"],"crossReferences":{"DrugCentral":["4431"]},"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL374699","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)n1","inchiKey":"NCMVOABPESMRCP-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-Deoxycytidinemonophosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxycytidinemonophosphate"],"crossReferences":{"Wikipedia":["Deoxycytidine_monophosphate"],"drugbank":["DB03798"],"chEBI":["15918"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3763421","canonicalSmiles":"Cl.Cl.NCCS","inchiKey":"MJZJRYUPMNKDQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3763421","maximumClinicalTrialPhase":0,"parentId":"CHEMBL602","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL386015","canonicalSmiles":"O=C(N[C@@H]1Cc2ccccc2[C@H]1O)c1cc2cc(Cl)sc2[nH]1","inchiKey":"LRHOLHTVXXSIMG-BXUZGUMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL386015","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL389433","canonicalSmiles":"Clc1cccc(C(c2ccc3nc[nH]c3c2)n2ccnc2)c1","inchiKey":"UGFHIPBXIWJXNA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIAROZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Liarozole","Liazal","R-75251"],"crossReferences":{"PubChem":["50125769"],"drugbank":["DB13066"]},"childChemblIds":["CHEMBL2105015","CHEMBL2105595"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3954447","canonicalSmiles":"CN(C)c1cc([14CH2]NCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"JEECQCWWSTZDCK-SVIJMGADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3954447","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1689772","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989798","canonicalSmiles":"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O.O.O=C(O)/C=C/C(=O)O","inchiKey":"RATSWNOMCHFQGJ-XODSYJLDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMOTEROL FUMARATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1256786","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atimos modulite","Foradil","Foradil certihaler","Oxis 12","Oxis 6","Performist","Perforomist"],"synonyms":["BD 40A","BD-40A","CGP 25827A","CGP-25827A","Eformoterol","Formoterol fumarate","Formoterol fumarate (superceded)","Formoterol fumarate dihydrate","Formoterol fumarate hydrate","NSC-299587","YM-08316"],"crossReferences":{"DailyMed":["formoterol%20fumarate","formoterol%20fumarate%20dihydrate"]},"count":11,"approvedIndications":["EFO_0000270","EFO_0000464","EFO_0006505","EFO_0000341"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0007183","EFO_0000270","EFO_0000464","MONDO_0008903","EFO_0006505","EFO_0009661","EFO_0003768","EFO_0000341","HP_0025428","EFO_1000637","EFO_0003785","HP_0002110"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 7 investigational indications."}
{"id":"CHEMBL3989805","canonicalSmiles":"CN1CCN(c2ccccc2/C=C2\\SCCN(c3ccc(Cl)c(Cl)c3)C2=O)CC1.Cl","inchiKey":"NMTRXBJYASHMND-UXTSPRGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELZASONAN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3185463","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-448,187-01","Cp-448187-01","Elzasonan hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989993","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"COBOMARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobomarsen","M-11667 FREE ACID","M11667","M11667 FREE ACID","MRG-106","MRG-106 FREE ACID"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3990032","drugType":"Antibody","blackBoxWarning":false,"name":"TELISOTUZUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-399","ABT-399","Abbv 399","PR-1420682","Telisotuzumab vedotin"],"count":3,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000105976","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000708","EFO_0003060","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL406863","canonicalSmiles":"NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1","inchiKey":"QOZMRRGNAZNWDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406863","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08148"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4089083","canonicalSmiles":"O/N=c1\\cc(-c2cc3sccc3cn2)oc2ccc(CCCN3CCOCC3)cc12","inchiKey":"ZTEDNASHAWNBKQ-NCELDCMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLIGLURAX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DT-1687","DT1687","Foliglurax","PXT-002331","PXT002331","Pxt002331"],"crossReferences":{"drugbank":["DB15292"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL409803","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C","inchiKey":"JYPVVOOBQVVUQV-CGHBYZBKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANGIOTENSIN AMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Angiotensin amide","Angiotensinamide"],"crossReferences":{"Wikipedia":["Angiotensinamide"],"drugbank":["DB13517"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4099995","canonicalSmiles":"CS(=O)(=O)O.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"UHZFGIQMKAWZGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4099995","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL414357","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O","inchiKey":"HTQBXNHDCUEHJF-XWLPCZSASA-N","drugType":"Protein","blackBoxWarning":true,"name":"EXENATIDE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bydureon","Bydureon bcise","Bydureon pen","Byetta"],"synonyms":["AC 2993","AC-002993","AC-2993","AC-2993A","AC-2993LAR","AC002993","AC2993","AC2993A","DA-3091","EXENDIN-4","Exenatide","Exenatide Synthetic","Exenatide synthetic","ITCA-650","LY-2148568","LY2148568"],"crossReferences":{"DailyMed":["exenatide","exenatide%20synthetic"]},"count":18,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0004566","EFO_0002610","EFO_0003095","EFO_0000401","HP_0001824","EFO_0003829","HP_0000083","EFO_0004593","EFO_0000712","MONDO_0015183","EFO_0000400","EFO_0002546","EFO_0000692","EFO_0007318","EFO_0004319","HP_0002140","EFO_0001074","EFO_0002508","EFO_0001645","EFO_0001073","EFO_0000660","EFO_1001050","EFO_1001121","EFO_0001359","HP_0003074","EFO_0008583","EFO_0000612","MONDO_0043510","EFO_0001360","EFO_0005411"],"count":30},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for type ii diabetes mellitus and diabetes mellitus and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL415049","canonicalSmiles":"CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O","inchiKey":"GBJVVSCPOBPEIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARASERTIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD 1152","AZD-1152","AZD1152","Azd-1152","Barasertib"],"crossReferences":{"PubChem":["103905346"],"drugbank":["DB11747"]},"count":4,"linkedTargets":{"rows":["ENSG00000178999"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000574","EFO_0000222","MONDO_0004643"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL42","canonicalSmiles":"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1","inchiKey":"QZUDBNBUXVUHMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOZAPINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clozapine","Clozaril","Fazaclo","Fazaclo odt","Versacloz","Zaponex"],"synonyms":["Clozapine","Clozapine resolution mixture","HF 1854","HF-1854"],"crossReferences":{"DailyMed":["clozapine"],"PubChem":["104171134","11110967","11110968","11113341","124879684","124879686","124879688","124879690","124879691","144203664","170464853","26747001","26751524","50104084","50104086","56422144","85230974","855811","90341777"],"Wikipedia":["Clozapine"],"drugbank":["DB00363"],"chEBI":["3766"]},"childChemblIds":["CHEMBL538973"],"count":9,"approvedIndications":["EFO_0005407","EFO_0005411","EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000195","EFO_0000289","MONDO_0002050","EFO_0004262","HP_0000726","EFO_0005407","EFO_0003847","EFO_0005230","EFO_0005411","EFO_0000692","EFO_0003852"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297208","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPLATIN TETRANITRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BBR 3464","BBR-3464","BBR3464","Bbr 3464","Triplatin tetranitrate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297245","drugType":"Antibody","blackBoxWarning":false,"name":"DONANEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Donanemab","LY 3002813","LY-3002813","LY3002813"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297312","canonicalSmiles":"COC[C@@]1(C)CCCN2CCc3c(oc4ccccc34)[C@@H]21","inchiKey":"OCUKPFWNSAAHRP-QZTJIDSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORM-12741","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORM-10921","Orm-12741"],"crossReferences":{"drugbank":["DB12057"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297375","canonicalSmiles":"Cc1cnc(C[S@@+]([O-])c2nc3ccccc3[n-]2)c(C)c1OCC1COC(C)(C)OC1.[Na+]","inchiKey":"HXDOUUHARCBYLF-VNUFCWELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELOPRAZOLE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4300945","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azeloprazole sodium","E-3710","E3710"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297399","canonicalSmiles":"O=C(Nc1ncc(SCCN2CCCC2)s1)[C@]1(c2ccc(S(=O)(=O)C3CC3)cc2)C[C@H]1C1CCCCC1","inchiKey":"QIIVJLHCZUTGSD-CUBQBAPOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2608204","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2608204","Ly-2608204","Ly2608204"],"crossReferences":{"drugbank":["DB12284"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297503","canonicalSmiles":"COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O","inchiKey":"RZVPBGBYGMDSBG-GGAORHGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALOXAVIR MARBOXIL","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xofluza"],"synonyms":["Baloxavir marboxil","S-033188"],"crossReferences":{"DailyMed":["baloxavir%20marboxil"],"drugbank":["DB13997"]},"count":2,"approvedIndications":["EFO_0007328","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for viral disease and influenza."}
{"id":"CHEMBL4297547","drugType":"Unknown","blackBoxWarning":false,"name":"COCO DIETHANOLAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cocamide diethanolamine","Coco diethanolamide"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297716","drugType":"Unknown","blackBoxWarning":false,"name":"CARBOGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbogen"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297727","drugType":"Unknown","blackBoxWarning":false,"name":"CHOLINE MAGNESIUM TRISALICYLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Choline magnesium trisalicylate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL4297765","drugType":"Unknown","blackBoxWarning":false,"name":"HT-2157","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HT-2157","Ht-2157","SNAP-37889"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297799","drugType":"Unknown","blackBoxWarning":false,"name":"OT-58","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OT-58","Ot-58"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297852","drugType":"Protein","blackBoxWarning":false,"name":"CENEGERMIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxervate"],"synonyms":["Cenegermin-bkbj"],"crossReferences":{"DailyMed":["cenegermin-bkbj"]},"count":1,"approvedIndications":["EFO_0009449"],"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0009449","EFO_1000906"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for keratitis."}
{"id":"CHEMBL4297877","drugType":"Antibody","blackBoxWarning":false,"name":"BALSTILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGEN-2034","AGEN2034","Agen2034","Balstilimab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297918","drugType":"Antibody","blackBoxWarning":false,"name":"SETRUSUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPS-804","BPS804","Bps804","MOR05813","Setrusumab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298046","drugType":"Unknown","blackBoxWarning":false,"name":"IRON ISOMALTOSIDE 1000","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iron isomaltoside 1000","Monofer"],"count":7,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4298047","drugType":"Antibody","blackBoxWarning":false,"name":"TAFASITAMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monjuvi"],"synonyms":["MOR-00208","MOR00208","MOR208","Mor00208","Tafasitamab","Tafasitamab-cxix","XmAb5574","Xmab5574"],"count":5,"approvedIndications":["EFO_0000403"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","MONDO_0001023","EFO_0000220","EFO_0000095","EFO_0000403","EFO_0005952"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for diffuse large b-cell lymphoma and has 4 investigational indications."}
{"id":"CHEMBL4298074","drugType":"Unknown","blackBoxWarning":false,"name":"POTASSIUM PHOSPHATE, UNSPECIFIED FORM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium phosphate","Potassium phosphate, unspecified form"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298183","drugType":"Antibody","blackBoxWarning":false,"name":"ATOLTIVIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atoltivimab","REGN3470"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL43185","canonicalSmiles":"O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1","inchiKey":"MXXWOMGUGJBKIW-YPCIICBESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 2909","NSC-21727","Piperine"],"crossReferences":{"PubChem":["144209188","144213063","26748436","26753730","56463241"],"Wikipedia":["Piperine"],"drugbank":["DB12582"],"chEBI":["28821"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL437747","canonicalSmiles":"CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1","inchiKey":"UQFRSHRWRKYNDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL437747","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905437"],"drugbank":["DB02388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL440283","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"QADHLRWLCPCEKT-LOVVWNRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTENEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstenediol"],"crossReferences":{"PubChem":["144206048","170465858","50112747"],"Wikipedia":["5-Androstenediol"],"drugbank":["DB01524"],"chEBI":["2710"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL443684","canonicalSmiles":"CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1","inchiKey":"JLYAXFNOILIKPP-KXQOOQHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVITOCLAX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-855071.0","ABT-263","Navitoclax"],"crossReferences":{"drugbank":["DB12340"]},"childChemblIds":["CHEMBL2105690"],"count":12,"linkedTargets":{"rows":["ENSG00000171552","ENSG00000258643","ENSG00000171791","ENSG00000129473"],"count":4},"linkedDiseases":{"rows":["EFO_0002430","EFO_0000616","EFO_0004251","MONDO_0000873","EFO_0000095","EFO_0001642","EFO_0000220","MONDO_0008170","EFO_0000403","EFO_0000702","EFO_0003060","MONDO_0008315"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL445162","canonicalSmiles":"CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"QTFCKBFCXDAZIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445162","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07253"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456","canonicalSmiles":"C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl","inchiKey":"AVOLMBLBETYQHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHACRYNIC ACID","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edecrin","Ethacrynic acid","Hydromedin","Reomax"],"synonyms":["Etacrynic acid","Ethacrynic acid","MK-595","NSC-624008","NSC-85791"],"crossReferences":{"DailyMed":["ethacrynate%20sodium","ethacrynic%20acid"],"PubChem":["104171276","11112144","122995","124881977","124881979","144203886","144208300","170465426","17389016","26746983","26746984","50100377","855762","92763949"],"Wikipedia":["Etacrynic_acid"],"drugbank":["DB00903"],"chEBI":["4876"]},"childChemblIds":["CHEMBL1200487"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000074803"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000516","MONDO_0001187"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL4581802","canonicalSmiles":"CS(=O)(=O)O.Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1","inchiKey":"GFCZFGQAHGKXLK-GMUIIQOCSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4581802","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3544964","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594234","drugType":"Small molecule","blackBoxWarning":false,"name":"FIRTECAN PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EZN-2208","Ezn-2208","Firtecan pegol"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594438","canonicalSmiles":"CC(C)(C#Cc1ccc(-c2ccc(Cl)c3c(NS(C)(=O)=O)nn(CC(F)(F)F)c23)c([C@H](Cc2cc(F)cc(F)c2)NC(=O)Cn2nc(C(F)(F)F)c3c2C(F)(F)[C@@H]2C[C@H]32)n1)S(C)(=O)=O","inchiKey":"BRYXUCLEHAUSDY-WEWMWRJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENACAPAVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-CA1","Lenacapavir"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594441","canonicalSmiles":"COc1cc(Nc2ncc(C)c(Nc3ccc4oc(=O)[nH]c4c3)n2)cc(C)c1F","inchiKey":"OYFMQDVLFYKOPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IFIDANCITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-301","ATI-502","Ati-502","Ifidancitinib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594501","drugType":"Unknown","blackBoxWarning":false,"name":"TAK-137","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-137"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594557","drugType":"Unknown","blackBoxWarning":false,"name":"EFTILAGIMOD ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eftilagimod alfa","IMP321","Imp321"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594566","drugType":"Antibody","blackBoxWarning":false,"name":"ONGERICIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JS 002","JS-002","Js002","Ongericimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594574","drugType":"Unknown","blackBoxWarning":false,"name":"LY-3415244","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-3415244","Ly3415244"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL479032","canonicalSmiles":"O=c1ccc(Cc2ccc(Cl)c(Oc3ccccc3)c2F)n[nH]1","inchiKey":"NOVPOXGMADEKPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL479032","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483","canonicalSmiles":"C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O","inchiKey":"SGOIRFVFHAKUTI-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOFOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atripla","GS-1275","PMP-A","Tenofovir","Truvada"],"crossReferences":{"Wikipedia":["Tenofovir"],"drugbank":["DB14126"],"chEBI":["63625"]},"childChemblIds":["CHEMBL3989702"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL488280","canonicalSmiles":"CCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]","inchiKey":"YZZCJYJBCUJISI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPATYL NITRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Etrynit"],"synonyms":["ETT-N","ETTN","Propatyl nitrate","Propatylnitrate","WIN 9317","WIN-9317"],"crossReferences":{"Wikipedia":["Propatylnitrate"],"drugbank":["DB13255"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL515","canonicalSmiles":"O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1","inchiKey":"JCKYGMPEJWAADB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORAMBUCIL","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Leukeran"],"synonyms":["CB-1348","Chlorambucil","Chlorbutin","NCI-3088","NSC-3088"],"crossReferences":{"DailyMed":["chlorambucil"],"PubChem":["104171121","11110896","11110897","124879524","124879525","144203647","144208588","144213313","170464770","17389986","174007440","26747015","50104127","50126363","56422109","69624","85230952","855863","90341264"],"Wikipedia":["Chlorambucil"],"drugbank":["DB00291"],"chEBI":["28830"]},"count":8,"approvedIndications":["EFO_0000616","EFO_0000220"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for acute lymphoblastic leukemia and neoplasm and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL515966","canonicalSmiles":"COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1","inchiKey":"XPNMCDYOYIKVGB-CONSDPRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZLOPITANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CJ-11, 974","Cj-11974","Ezlopitant"],"crossReferences":{"Wikipedia":["Ezlopitant"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL539163","canonicalSmiles":"Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(C)OC(=S)N2","inchiKey":"PYVFWTPEBMRKSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANAPROGET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSP-989","Tanaproget"],"crossReferences":{"drugbank":["DB04787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550","canonicalSmiles":"CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C","inchiKey":"QCHFTSOMWOSFHM-WPRPVWTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PILOCARPINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ocusert pilo","Ocusert pilo-20","Ocusert pilo-40"],"synonyms":["Pilocarpine"],"crossReferences":{"DailyMed":["pilocarpine%20hydrochloride"],"PubChem":["11113352","170464845","26751548","50104139","90340957","90341610"],"Wikipedia":["Pilocarpine"],"drugbank":["DB01085"],"chEBI":["8207"]},"childChemblIds":["CHEMBL2139597","CHEMBL1200330","CHEMBL1213136"],"count":6,"approvedIndications":["EFO_0000516"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0004190","EFO_1001069","EFO_0006859","MONDO_0001744","HP_0000020","EFO_1001914","EFO_0000516","EFO_0009869"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for glaucoma and has 5 investigational indications."}
{"id":"CHEMBL570680","canonicalSmiles":"CC(C)(N)CNC(=O)C[C@H]1CC[C@]2(CC1)OO[C@]1(O2)C2CC3CC(C2)CC1C3.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"ZNEZSLAXOUSCDT-KDJJSNTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEROLANE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL404431","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arterolane","OZ 277","OZ-277","RBX-11160","RBX11160"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL573352","canonicalSmiles":"C#C[C@@]1(O)[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@@H]1O","inchiKey":"JFIWEPHGRUDAJN-DYUFWOLASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-106","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-C-Ethynylcytidine","3'-C-Ethynylcytidine","Tas 106","Tas-106"],"crossReferences":{"drugbank":["DB06656"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL578","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"GBXSMTUPTTWBMN-XIRDDKMYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRIL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C09AA02","Enalapril","Lexxel","Vaseretic","Vasotec"],"crossReferences":{"DailyMed":["enalapril%20maleate"],"PubChem":["11112847","144204423","170464969","29214998"],"TG-GATEs":["95"],"Wikipedia":["Enalapril"],"drugbank":["DB00584"],"chEBI":["4784"]},"childChemblIds":["CHEMBL1200659"],"count":21,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000756","EFO_0000401","EFO_0004234","EFO_0000318","EFO_0005669","EFO_0000373","EFO_0003914","EFO_1001375","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0004289","EFO_1002032","EFO_0000280","EFO_0000685","MONDO_0018638","HP_0000093","EFO_0000556","EFO_0000222","EFO_0000319","EFO_0004194","EFO_0000537","EFO_0000311","HP_0012664","MONDO_0100096","EFO_1001482","EFO_0001359","EFO_0001378","EFO_0000668"],"count":30},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for cardiovascular disease and has 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL583969","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"OLCWZBFDIYXLAA-IOSLPCCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11532930","26756681"],"drugbank":["DB03148"],"chEBI":["40730"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL589001","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O.O=S(=O)(O)O","inchiKey":"ZYCWGZVLCXRARB-HZQSTTLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TCMDC-123939","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-123939"],"crossReferences":{"PubChem":["56320740","56323657"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61872","canonicalSmiles":"CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3","inchiKey":"JACAAXNEHGBPOQ-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GYKI-53773","LY-300164","Talampanel"],"crossReferences":{"Wikipedia":["Talampanel"],"drugbank":["DB04982"],"chEBI":["34992"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL66412","canonicalSmiles":"CN(C(=O)Oc1ccc(Cl)cc1)[C@H]1CC[C@H](c2ccc(CN3CCCCC3)cc2)CC1","inchiKey":"AMKFOVYTEUFMCU-HCGLCNNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL66412","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03748"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL723","canonicalSmiles":"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12","inchiKey":"OGHNVEJMJSYVRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARVEDILOL","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carvedilol","Coreg","Coreg CR","Eucardic 12.5","Eucardic 25","Eucardic 3.125","Eucardic 6.25"],"synonyms":["BM 14.190","BM-14-190","BM-14.190","BM-14190","C07AG02","Carvedilol","DQ-2466","SKF-105517"],"crossReferences":{"DailyMed":["carvedilol","carvedilol%20phosphate"],"PubChem":["26719722","26719723","50112972","50112973","90341342"],"Wikipedia":["Carvedilol"],"drugbank":["DB01136"],"chEBI":["3441"]},"childChemblIds":["CHEMBL1201167","CHEMBL1437006"],"count":29,"approvedIndications":["EFO_0003144","EFO_0000373","EFO_0000319","EFO_0000612","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778"],"count":6},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001361","EFO_0002610","Orphanet_98895","EFO_0000275","EFO_0000249","MONDO_0007254","EFO_0003768","EFO_0000373","EFO_0009094","EFO_0003913","EFO_0003914","EFO_0000474","EFO_0008585","EFO_0003144","EFO_0004289","EFO_1002032","EFO_0000407","EFO_0008586","MONDO_0005149","HP_0003124","EFO_0001645","EFO_0000222","EFO_0000319","EFO_0001358","EFO_0000666","EFO_0001073","MONDO_0008315","EFO_0000537","EFO_0000311","Orphanet_98896","MP_0001914","EFO_0001422","HP_0012664","EFO_0003896","EFO_0000574","EFO_0008583","EFO_0009545","EFO_0000612","HP_0001943","EFO_0000341","EFO_0001378","EFO_0001360","EFO_0000519","EFO_0005672","HP_0012594","EFO_0004264"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 5 approved and 24 investigational indications."}
{"id":"CHEMBL74632","canonicalSmiles":"CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21","inchiKey":"JWCSIUVGFCSJCK-CAVRMKNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXALACTAM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Latamoxef","Moxalactam","Moxam"],"crossReferences":{"Wikipedia":["Latamoxef"],"drugbank":["DB04570"],"chEBI":["599928"]},"childChemblIds":["CHEMBL1200357"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for bacterial disease."}
{"id":"CHEMBL7728","canonicalSmiles":"CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O","inchiKey":"UYXAWHWODHRRMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOBARBITAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Evipal","Sombucaps","Sombulex"],"synonyms":["Enhexymal","Hexobarbital"],"crossReferences":{"PubChem":["144205214","170465860","26754503","29215369","47194291"],"Wikipedia":["Hexobarbital"],"drugbank":["DB01355"],"chEBI":["5706"]},"childChemblIds":["CHEMBL2104880"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL77622","canonicalSmiles":"Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O","inchiKey":"RYBJORHCUPVNMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOPEXAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dopexamine","FPL 60278","FPL-60278"],"crossReferences":{"PubChem":["124896575","144206582","170466408"],"Wikipedia":["Dopexamine"],"drugbank":["DB12313"]},"childChemblIds":["CHEMBL3989581"],"count":2,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL8","canonicalSmiles":"O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O","inchiKey":"MYSWGUAQZAJSOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CIPROFLOXACIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cetraxal","Ciloxan","Cipro","Ciprobay","Ciprofloxacin","Otiprio","Velmonit"],"synonyms":["BAY O 9867 FREE BASE","BAY Q 3939","BAY-O-9867 FREE BASE","BAY-Q-3939","BAYQ3939","Ciloxan","Ciprofloxacin"],"crossReferences":{"DailyMed":["ciprofloxacin","ciprofloxacin%20hydrochloride"],"PubChem":["11112875","124882697","174007333","26748814"],"TG-GATEs":["50"],"Wikipedia":["Ciprofloxacin"],"drugbank":["DB00537"],"chEBI":["100241"]},"childChemblIds":["CHEMBL3764828","CHEMBL4303345","CHEMBL1077975","CHEMBL1202"],"count":45,"approvedIndications":["EFO_0003103","EFO_0000771","EFO_0000544","EFO_1001141","EFO_1000025","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 6 approved and 39 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL833","canonicalSmiles":"Clc1ccccc1CN1CCc2sccc2C1","inchiKey":"PHWBOXQYWZNQIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TICLOPIDINE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ticlopidine"],"crossReferences":{"DailyMed":["ticlopidine%20hydrochloride"],"PubChem":["104171328","11112786","124882626","144204209","170464698","26751617","50085878"],"TG-GATEs":["146"],"Wikipedia":["Ticlopidine"],"drugbank":["DB00208"],"chEBI":["9588"]},"childChemblIds":["CHEMBL1717"],"count":3,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0000712","MONDO_0002679","HP_0004419","EFO_0004265","EFO_0002615"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for recurrent thrombophlebitis and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL96741","canonicalSmiles":"Fc1ccc(-c2ncn(CC3CC3)c2-c2ccncc2)cc1","inchiKey":"ROKOFZNQCIIJMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-216995","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-216995"],"crossReferences":{"drugbank":["DB08522"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
